bioMérieux Reports the US FDA’s 510(k) Clearance of VITEK COMPACT PRO for Pathogen Detection & Antibiotic Susceptibility Testing
Shots:
- The US FDA has granted 510(k) clearance to VITEK COMPACT PRO for microorganism identification (ID)& antibiotic susceptibility testing (AST); initially available in select countries, with global launch planned in Q2’25
- COMPACT PRO combines advanced diagnostics with VITEK 2 COMPACT’s benefits, offering an ergonomic design & simplified workflow to improve efficiency, reduce handling time, & deliver faster ID/AST results, with microbiology expertise for diagnostic accuracy
- COMPACT PRO can be used for routine pathogen detection in the food, pharma, & cosmetic industries, while also helping small & medium-sized labs transition from manual workflows to automation
Ref: Prnewswire | Image: bioMérieux
Related News:- Perfuze Secures the US FDA’s 510(k) Clearance for its Zipline Access Catheters
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Ridhi is an avid secondary researcher who follows trends in the biopharmaceutical and healthcare sectors to curate engaging content for the global audience. She works as a news editor at PharmaShots and loves to read books and explore new destinations.
